NeurogesX Company
NeurogesX develops and commercializes therapies for chronic peripheral neuropathic pain.
Headquarters:
United States
Industry:
Genomic and Epigenominc Instabillity
Employee Number:
11-50
Investment Stage:
N/A
Investor Type:
N/A
Funding Status:
N/A
Number Of Exists:
N/A
Technology:
Neuromodulation
Founded Date:
1998